Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 1
2003 2
2004 7
2005 6
2006 2
2007 6
2008 5
2009 6
2010 6
2011 7
2012 10
2013 8
2014 7
2015 2
2016 2
2017 2
2018 3
2019 2
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 25987236

70 results
Results by year
Filters applied: . Clear all
Page 1
Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk. MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk. Breast Cancer Res Treat. 2010 Jan;119(2):463-74. doi: 10.1007/s10549-009-0407-0. Epub 2009 May 8. Breast Cancer Res Treat. 2010. PMID: 19424794
Low dietary riboflavin but not folate predicts increased fracture risk in postmenopausal women homozygous for the MTHFR 677 T allele.
Yazdanpanah N, Uitterlinden AG, Zillikens MC, Jhamai M, Rivadeneira F, Hofman A, de Jonge R, Lindemans J, Pols HA, van Meurs JB. Yazdanpanah N, et al. J Bone Miner Res. 2008 Jan;23(1):86-94. doi: 10.1359/jbmr.070812. J Bone Miner Res. 2008. PMID: 17725378 Free article.
70 results
Jump to page
Feedback